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 Abstract - New digital technologies can have a 
huge impact on the traditional healthcare sector, both 
from a clinical and economic perspective. Doctors and 
health specialists will increasingly need technology to 
improve the services they provide to their patients. 
Here a novel patented device for automatic processing 
of clinical data of chronic poly-pathological patients 
is presented. The invention consists of a 
reconfigurable equipment that allows the assessment 
of clinical risk severity indexes that can be customized 
for polypathological patients and which acts both as a 
decision support system for specialist doctors in the 
diagnosis and treatment phases, and as a monitoring 
system in the clinical environment. 
 
Keywords: digital innovation, clinical decision-making, 
chronic patients 
 
I.  INTRODUCTION 
 
Digital technologies have successfully 
transformed most sectors of the economy, ranging from 
finance to entertainment, with a significant impact on 
healthcare. The huge investments in digital health 
technologies by start-ups and established technological 
companies aim in fact at a radical transformation of health 
services. 
Although the healthcare sector is complex and the 
introduction of technological and digital innovations 
requires important "change management" work so that the 
technological solutions are integrated into the assistance 
processes and adopted in clinical practice, it is becoming 
increasingly dependent on digital technologies to improve 
patient-specialist communication, provide efficient clinical 
treatments, optimize the diagnosis of dangerous diseases, 
reduce threats to public health and optimize health services 
globally. The future of the health sector is therefore deeply 
tied to technological progress. 
New technologies will continue to change the 
traditional healthcare sector as we know it, influencing this 
market from different perspectives. On the one hand, it will 
have an impact on the commercial side of the sector, which 
means that companies and organizations will be able to 
more precisely deliver optimized services to customers and 
increase profitability. On the other hand, it will influence 
the services provided by industry by discovering new ways 
of treating diseases, optimizing diagnoses and improving 
delicate decision-making processes. Doctors and health 
specialists will increasingly need technology to improve the 
services they provide to their patients. Technological and 
digital innovation will help doctors in their different fields, 
from improving accuracy during the execution of a 
complicated operation, to optimizing a diagnosis using 
intelligent systems capable of understanding health 
problems and complicated diseases. 
Among the most innovative digital tools in the 
field of healthcare, the use of artificial intelligence plays a 
fundamental role. In the medical field, artificial intelligence 
is based on the analysis and interpretation of huge 
quantities of data sets in order to help doctors make better 
decisions, effectively manage information on patient data, 
create personalized medicine plans from complex data sets 
and discover new drugs. Among the applications of 
artificial intelligence, we find: 
- Clinical decision support: artificial intelligence 
proves useful in the context of clinical decision 
support to help doctors make better decisions faster 
with the recognition of patterns of health 
complications recorded much more accurately than 
the human brain. Time saved and diagnosed 
conditions are critical in an area where time spent and 
decisions made can change patients' lives. 
- Information management: artificial intelligence in 
healthcare is an excellent addition to information 
management for both the doctor and the patient. With 
patients turning to doctors faster or not at all when 
using telemedicine, valuable time and money are 
saved, eliminating the effort of healthcare 
professionals and increasing patient comfort. 
- Discovery of new drugs: health and pharmaceutical 
companies currently exploit artificial intelligence as a 
support tool for the discovery of new drugs to 
optimize the long timescales and processes related to 
the discovery and approval of a new drug, from 
clinical tests to its placing on the market. 
The use of artificial intelligence to support clinical 
decisions, in particular, is the subject of a recent patent 
developed developed at the Public Health Department of 
the School of Medicine and Surgery of the Federico II 
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University of Naples by: Prof. Maria Triassi (deputy 
director of the Department), Dr. Giovanni Improta 
(researcher of the Department), Dr. Vincenzo Abate (then 
postdoctoral fellow of the Department), Dr. Mario 
Alessandro Russo (PhD student of the Department), Prof. 
Stefania Santini (Associate Professor of DIETI, 
Department of Electrical Engineering and Information 
Technologies of the same University) and Dr. Antonio 
Saverio Valente (post-doc of DIETI). This is an innovative 
system for supporting complex clinical decisions based on 
artificial intelligence. The Device is a system based on 
hardware components that processes and manages in real 
time all information of a chronic patient, also evaluating 
global severity indices, enucleated from elementary 
parameters characteristic of the pathology or the poly-
pathological set (settable). 
In the medical-health field are usually used 
medical records in paper format (usually residing in the 
hospital structures of competence) and only recently, and 
in some specific cases, the electronic record of the patient 
(electronic medical record). However, these tools do not 
allow the doctor to obtain synergic and comprehensive 
information, and, therefore, the overall concise and 
efficient assessment of the patient's health and risk state, 
especially in the case of chronic polypathological patients, 
where the risk of aggravations due to complications, and 
the risk of death, it is very high. 
In the following, we report a literature review of 
the state of the art related to the field of application of the 
invention. 
- Kasabov et al. [1] propose a decision support system 
based on Bayesian techniques whose application is 
focused to the exploiting of genetic information for 
the diagnosis of some types of diseases. The idea is to 
extract relational rules among gene sets and clinical 
data in order to highlight the incipient onset of some 
types of diseases, that can be treated through 
customizable gene treatments. 
- A system for supporting medical decisions is instead 
proposed in Schmidt et al. [2], where the proposed 
invention restricts the use of data mining techniques 
only to similarity analysis with respect to patient 
clusters. 
- The application of fuzzy logic to medical decisions is 
instead proposed in Park et al. [3] where the method 
includes a multi-stage acquisition of clinical data but 
it is limited to a single target pathology, therefore it 
does not explicitly consider the coexistence of 
multiple pathologies and factors of high comorbidity. 
- The creation of an automatic system for generating an 
Electronic Health Record (EHR), that integrates all 
the patient's health data collected from public and 
private information systems, is the object of the 
invention by Vishnubhatla Suresh-Kumar Venkata et 
al. [4]. 
More classical approaches use decision support systems 
only as interfaces to access and update patient records. 
- This kind of approach is for example followed by 
Mack et al. in [5] where the system is able in handling 
large amounts of clinical data, but not predicting 
patient status and risk analysis. 
- Likewise, Tremper in [6] proposes a device for 
compiling the electronic medical record based on data 
from the acquisition of fundamental clinical variables. 
- Randazzo et al. [7] instead focus on the generation of 
alarm signals but the tool uses very simple 
comparative methods that only verify if some 
temporal patterns of data exceed a priori pre-
established thresholds. 
- Lee et al. [8] instead propose the implementation of 
algorithms of semantics and ontology for the 
selection, extraction, and storage of information from 
data, also recorded with natural language. 
The advantages of such a novel device are: i) limitlessness 
in the numbers of parameters that can be simultaneously 
evaluated and constantly monitored in their variations; ii) 
possibility of evaluating the patient's response to a given 
pharmacological treatment to verify its effectiveness; iii) 
possibility of evaluating the patient's response to eventual 
changes in his lifestyle. 
 
II.  METHODOLOGY 
 
In the invention, a dedicated hardware elaboration 
system manages automatically and processes in real-time 
all the patient's clinical data and the main clinical variables 
for both diagnosis and treatment support, also detecting any 
shortcomings in analyzed data. For example, in the 
illustrative case of a patient affected by beta-thalassemia, 
by using the invention it is possible to optimize treatment 
scheduling defining precisely the date of the next 
transfusion. Or, if we consider the case of a patient with 
diabetes mellitus (DM), for whom the first cause of death 
is cardiovascular disease (MCV) when an early 
arteriosclerosis occurs, our invention can highlight to the 
clinician, thanks to specific alerts, the lack of the "value of 
ferritin in the blood" (identified as a significant 
cardiovascular risk index) by automatically analysing the 
data of the chronic patient and/or the presence of out-of-
range clinical parameters, effectively supporting the doctor 
during the diagnostic or treatment prescriptions phases, 
thus preventing clinical risks. 
Figure 1 represents a rough schematic view of the 
hardware realization of the equipment and is one of the 
examples of implementation. 
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Fig. 1.  schematic view of the hardware realization of the equipment. 
 
The device processes clinical data and allows, 
through continuous monitoring and computerized 
management of the state of health, the prevention of clinical 
risk in chronic polypathological patients, for whom no tools 
are currently available that allow an efficient assessment of 
the state of health and clinical risk. 
The device looks like a portable on-chip container, 
scalable and accessible even remotely, providing the 
caregiver with a global and dynamic view of the patient's 
clinical status according to elementary parameters that can 
be set by the doctor, with the additional advantage of being 
able to check the effectiveness of a drug treatment and / or 
the effect of a change in the subject's lifestyle. The 
definition and evaluation of personalized indicators relating 
to the severity of the clinical condition of the chronic 
polypathological patient also allows the establishment and 
setting of specific alarm thresholds relating to the various 
pathologies affecting the individual and consequently to 
correct the therapeutic approach based on the outputs 
provided from the device. 
 
III.  RESULTS AND DISCUSSION 
 
The device, easy to use for doctors, offers them a 
complete picture of the patient and the consequent 
possibility of defining a more appropriate diagnostic-
therapeutic-assistance procedure. All this is strictly 
connected to an optimization of the costs and resources 
used in the mana5rfgement of this type of patients whose 
health status, due to the concomitance of different 
pathologies and the absence of specific indicators, proves 
to be difficult both to determine and to to monitor. 
The following is an elementary example that 
contemplates the use of only two input variables, identified 
in "proteinuria" and in the "glomerular filtration rate" 
(eGFR), fundamental for monitoring the progression of 
chronic renal failure, and of a global index representative 
of the degree of severity of the disease itself (see figure 2 
for the entry-exit scheme). 
 
 
Fig. 2.  Entry-exit scheme. 
 
This decision support system also allows the 
clinician to explore patient data or suitably clustered patient 
groups, selecting the parameters to be monitored and the 
type of representation (which can for example be graphic / 
tabular). Figure 3 shows an example of monitoring the 
temporal trend of two parameters (Hb and Ht) related to the 
blood count of a generic patient. 
 
 
Fig. 3.  Example of monitoring the temporal trend of two parameters 
(Hb and Ht) related to the blood count of a generic patient. 
 
The system also provides for the possibility of 
showing summary dashboards divided by area (liver, 
cardiac etc.) containing the most significant coloured 
parameters according to the belonging range and the 
display of alert messages in the case of values higher than 
the critical thresholds established in relation to the patient's 
pathology and characteristics (gender, age etc ..). Figure 4 
shows an example of a summary picture for the kidney area 




Fig. 4.  Summary picture for the kidney area related to a patient 
with chronic kidney disease. 
 
To sum up, hte invention has the advantage of: 
- Offer a complete and easy to understand the picture of 
the clinical status of the polypathological patient; 
- Allowing the real-time automatic monitoring of the 
patient's health status; 
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- Optimize the treatment schedule, defining in a more 
accurate and customizable way, the most appropriate 
date for the next visit/treatment on the basis of the 
inference results of all clinical and diagnostic data; 
- Optimize clinical activities in terms of costs, the 
duration of the visits and related efforts; 
- Produce visual alerts at the occurrence of out of range 
events in the clinical parameters or in severity index; 
- Generate automatically customized global indicators 
related to the severity of a disease and its comorbid 
factors, thus providing to the physician quick 
assessment of the patient's clinical status and the 
precise suggestion about results coming from 
therapeutic actions pursued or to be pursued; 
- Support the doctor in the definition of any corrective 
action (e.g., to dose increase/reduction of a given 
drug); 
- Provide tools for statistical analysis, prediction, and 
visualization of any trend related to the characteristic 
parameters of the pathology and their possible 
correlations; 
- Cluster the patients' cohorts on the base of meaningful 
parameters (settable by users) for the definition of 
groups of patients with similar behaviours, that hence 
can be also exploited as benchmarks during diagnosis 
and decision making processes. 
The use of calculation systems that operate with a 
logic that emulates the evaluation process of the physician, 
but at the same time guarantees the objectivity of the result 
that is not influenced by external factors, allows saving the 
time and the energy involved into the decision-making 
process. 
A further purpose of the device is the aid to the 
research activities since the system allows the researcher to 
easily and in real time study the clinical data of a single 
patient in order to obtain feedback on the treatments 
performed with respect to suitably selected and clustered 
patient groups. In fact, it provides tools for statistical 
analysis, data mining and fuzzy logic, for the automatic 
extraction of correlations between all or part of the 
monitored parameters, allowing the extraction of implicit 
information in the data and significant patterns. 
 
IV.  CONCLUSION 
 
The creation of this promising decision-making 
tool is one of the numerous demonstrations of how the 
intuition and experience of the experts of the Public Health 
Department of University of Naples Federico II, who has 
always been committed to health prevention, medical-
scientific research and the interdisciplinary management of 
health activities, together with the opportunities offered by 
technological and digital progress, can expertly translate 
into an innovative product, concrete but above all 
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